Sanofi Canada invests in prostate cancer research

Collaboration with the GU Radiation Oncology Group of Quebec and the Segal Cancer Centre at the Jewish General Hospital (JGH)

02-May-2012 - Canada
Sanofi Canada is supporting a five-year study on radiation therapy and prostate cancer. Dr. Tamim Niazi of the Quebec Radiation Oncology GU Group and the JGH is the lead researcher. Sanofi Canada President and CEO, Hugh O'Neill and members of Sanofi's Oncology Team celebrate the collaboration.
CNW Group/SANOFI CANADA

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances